AI Capital Risk Diagnostic

Know your capital posture before you commit.

Get a clear, board-ready authorization posture before committing capital beyond the pilot stage.

The diagnostic answers the only question that matters before capital is committed:

Should you scale now, scale with constraints, or pause?

In one short session, you'll get a clear decision and the reasoning behind it.

This is executive decision support, not a product trial. Outputs are delivered in board-ready language.

Confidential. No obligation. Response within 1 business day.

Step 1 of 2

Get Your AI Capital Risk Diagnostic

See your authorization posture before committing capital

We'll gather a few details and schedule a focused working session with your team.

Confidential • No obligation
Delivered through a focused working session with your leadership team

Response within 1 business day

What you'll leave with

Decision-grade outputs for your next capital authorization conversation.

  • Authorization postureA clear answer—Pause, Controlled Investment, or Authorize Deployment—and the logic behind it.
  • AI Capital Risk Index (ACRI) — a single exposure score to anchor capital and risk tradeoffs
  • Primary structural constraints — the two to three factors that currently limit safe scale
  • Capital and operating implications — where exposure concentrates before you commit more
  • Prioritized next steps — executive-ready actions to move to the next posture

Framed for executive and board use—not implementation checklists.

Full AI Capital Risk Instrument

After posture is clear, teams often request the full instrument: a 20+ page board-level report with deeper capital exposure mapping and a sequenced path to scale—when that level of detail is warranted.